Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00590-002-0052-3 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Correction: Efficacy of liposomal irinotecan + 5-FU/LV vs. S-1 in gemcitabine-refractory metastatic pancreatic cancer: a real-world study using inverse probability of treatment weighting.
J Gastroenterol
January 2025
Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan.
Correction: Targeting the vasopressin type-2 receptor for renal cell carcinoma therapy.
Oncogene
January 2025
The Jared Grantham Kidney Institute, University of Kansas Medical Center, Kansas City, KS, USA.
Corrigendum: Case Report: A rare presentation of rapidly progressive moyamoya disease refractory to unilateral surgical revascularization.
Front Surg
January 2025
Cerebrovascular and Endovascular Neurosurgery, Southeast Health, Dothan, AL, United States.
[This corrects the article DOI: 10.3389/fsurg.2024.
View Article and Find Full Text PDFCorrigendum to "Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer": [ESMO Open 9 (2024) 103647].
ESMO Open
January 2025
INSERM U1279, Université Paris-Saclay, Villejuif, France; Department of Cancer Medicine, Gustave Roussy, Villejuif, France.
Corrigendum to "Functional implications of rs9373441 with FOXP3+Treg and Tr1 for the clinical effectiveness of csDMARDs in rheumatoid arthritis" [Clinica Chimica Acta 551 (2023) 117612].
Clin Chim Acta
January 2025
School of Public Health, National Defense Medical Center, ROC, Taipei, Taiwan. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!